Early buyers will receive 10% customization on this report.
The Venipuncture Procedure Analysis report studies the total volume of venipuncture procedure and successful number of venipuncture procedures/interventions in the U.S., Canada, the U.K. (including Ireland), Germany, France, Italy, Spain, Benelux (Belgium, the Netherlands, and Luxembourg),Nordic countries (Denmark, Finland, Iceland, Norway, and Sweden), Australia, Switzerland, and Austria. The U.S. total venipuncture procedure volume contributed the largest share in 2016 and poised to grow at a CAGR of 1.8%.
The modest growth is due to the technological advancement in venipuncture procedure resulting in increasing successful venipuncture procedures. The increase in successful venipuncture procedure will eventually decrease the number of unsuccessful venipuncture attempts and total number of venipuncture procedure.
The surgical puncture of a vein, especially for the withdrawal of a blood sample for diagnostic purpose is called venipuncture. Venipuncture can be done through venous access. The fingerstick method of blood sample collection has not been considered while studying the venipuncture procedures, as, by definition, it is not the direct puncturing of a vein.
This study covers the venipuncture procedure analysis based on the success rate (total venipuncture and successful venipuncture), vein type (cephalic vein, median cubital vein, basilic vein, and other veins), end user [hospitals (public and private), diagnostic laboratories, physician office laboratories, and other end users], and geographic countries (the U.S., the U.K., Germany, France, Canada, Spain, Italy, Benelux, Nordic Countries, Australia, Switzerland, and Austria).
Based on vein type, the U.S. venipuncture procedures are classified into median cubital vein, cephalic vein, basilic vein, and other veins. The other veins segment includes great saphenous, femoral, scalp, subclavian, and metacarpal veins. The procedures in each vein type are further divided into total venipuncture procedures and successful venipuncture procedures. In 2016, the median cubital vein segment is expected to account for the largest share of the venipuncture procedures.
Based on end user, the U.K. venipuncture procedures are classified into hospitals, diagnostic laboratories, physician office laboratories, and others. The others segment includes home care, long-term acute care, and nursing homes. In 2016, the hospitals segment is expected to account for the largest share of the venipuncture procedures.
The Germany vein type segment is divided into median cubital vein, cephalic vein, basilic vein, and other veins. The other veins segment includes great saphenous, femoral, scalp, subclavian, and metacarpal veins. In 2016, the median cubital vein segment is expected to account for the largest share of the venipuncture procedures. Based on end user, the Germany venipuncture procedures are segmented into hospitals, diagnostic laboratories, physician office laboratories, and others. The others segment includes home care, long-term acute care, and nursing homes. In 2016, the hospitals segment is expected to account for the largest share of the venipuncture procedures.
About MarketsandMarkets:
MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. For more information, please visit www.marketsandmarkets.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
